An integrated system to study multiply substituted human immunodeficiency virus type 1 reverse transcriptase

被引:51
作者
Boretto, J
Longhi, S
Navarro, JM
Selmi, B
Sire, J
Canard, B
机构
[1] CNRS, UMR 6098, F-13288 Marseille 09, France
[2] Univ Aix Marseille 1, ESIL, CNRS, AFMB, F-13288 Marseille, France
[3] Univ Aix Marseille 2, ESIL, AFMB, CNRS, F-13288 Marseille 09, France
[4] INSERM, U372, F-13288 Marseille 09, France
关键词
D O I
10.1006/abio.2001.5045
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
We describe a gene system allowing the facile production of multiply substituted reverse transcriptases (RTs), the enzymatic characterization of these purified RTs, and the study of these mutations in the defined genetic background of the macrophage-tropic, non-laboratory-adapted human immunodeficiency virus type 1 (HIV-1) AD8 strain. Thirteen unique silent restriction sites were introduced in the pol gene encoding HIV-1 RT, allowing easy introduction of mutations. To simplify genetic manipulation and generate p66/p51 heterodimers in Escherichia coli, a gene construct of the viral protease alone was optimized for expression from a separate vector carrying a p15A origin of replication. Acitve-site titration experiments using pre-steady-state kinetics showed that our system yields a higher proportion of active enzyme than that obtained by alternate methods. To facilitate phenotype/genotype correlations, the modified RT gene was designed to be easily reintroduced into a recombinant proviral AD8 HIV-1 DNA, Infectious viruses made from this vector were undistinguishable from wild-type AD8 HIV-1, an isolate able to infect peripheral blood mononuclear cells and macrophages, Thus, the pot gene can tolerate many silent mutations in the polymerase domain without affecting the functionality of the HIV-1 genome. The system was validated biochemically and virologically using the V75T substitution associated with stavudine resistance. (C) 2001 Academic Press.
引用
收藏
页码:139 / 147
页数:9
相关论文
共 21 条
[1]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[2]   CASSETTE MUTAGENESIS OF THE REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
BOYER, PL ;
FERRIS, AL ;
HUGHES, SH .
JOURNAL OF VIROLOGY, 1992, 66 (02) :1031-1039
[3]   The motif D loop of human immunodeficiency virus type 1 reverse transcriptase is critical for nucleoside 5′-triphosphate selectivity [J].
Canard, B ;
Chowdhury, K ;
Sarfati, R ;
Doublié, S ;
Richardson, CC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (50) :35768-35776
[4]   Enhanced binding of azidothymidine-resistant human immunodeficiency virus 1 reverse transcriptase to the 3′-azido-3′-deoxythymidine 5′-monophosphate-terminated primer [J].
Canard, B ;
Sarfati, SR ;
Richardson, CC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (23) :14596-14604
[5]   CHARACTERIZATION OF THE DIMERIZATION PROCESS OF HIV-1 REVERSE-TRANSCRIPTASE HETERODIMER USING INTRINSIC PROTEIN FLUORESCENCE [J].
DIVITA, G ;
RESTLE, T ;
GOODY, RS .
FEBS LETTERS, 1993, 324 (02) :153-158
[6]   A MOLECULAR CLONE OF HTLV-III WITH BIOLOGICAL-ACTIVITY [J].
FISHER, AG ;
COLLALTI, E ;
RATNER, L ;
GALLO, RC ;
WONGSTAAL, F .
NATURE, 1985, 316 (6025) :262-265
[7]   Explanation of pre-steady-state kinetics and decreased burst amplitude of HIV-1 reverse transcriptase at sites of modified DNA bases with an additional, nonproductive enzyme-DNA-nucleotide complex [J].
Furge, LL ;
Guengerich, FP .
BIOCHEMISTRY, 1999, 38 (15) :4818-4825
[8]   IDENTIFICATION OF A HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE CLEAVAGE SITE WITHIN THE 66,000 DALTON SUBUNIT OF REVERSE-TRANSCRIPTASE [J].
GRAVES, MC ;
MEIDEL, MC ;
PAN, YCE ;
MANNEBERG, M ;
LAHM, HW ;
GRUNINGERLEITCH, F .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 168 (01) :30-36
[9]  
KATI WM, 1992, J BIOL CHEM, V267, P25988
[10]   AIDS VIRUS REVERSE-TRANSCRIPTASE DEFINED BY HIGH-LEVEL EXPRESSION IN ESCHERICHIA-COLI [J].
LARDER, B ;
PURIFOY, D ;
POWELL, K ;
DARBY, G .
EMBO JOURNAL, 1987, 6 (10) :3133-3137